title: The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes.
authors.affiliation: Neurochemistry Research Laboratories, New York University Medical Center, New York 10016.
authors.forename: M
authors.initials: M
authors.lastname: Goldstein
authors.forename: A N
authors.initials: AN
authors.lastname: Lieberman
authors.forename: N
authors.initials: N
authors.lastname: Takasugi
authors.forename: Y
authors.initials: Y
authors.lastname: Shimizu
authors.forename: S
authors.initials: S
authors.lastname: Kuga
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000008:administration & dosage*; D001921:Brain / Q000187:drug effects*; D004292:Dominance, Cerebral / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000008:administration & dosage*; D000882:Haplorhini; D006801:Humans; D009434:Neural Pathways / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects*
chemical_list: D000978:Antiparkinson Agents; D015259:Dopamine Agents; D011954:Receptors, Dopamine; D004298:Dopamine